Avalyn Pharma Inc. · NASDAQ:AVLN
Baranowski Lyn sold 52,500 Avalyn Pharma Inc. shares (Form 4)
Traded Nov 17 to Nov 18, 2026 · Filed Nov 19, 2026
From Nov 17 to Nov 18, 2026, Baranowski Lyn (Director, Chief Executive Officer) sold 52,500 Avalyn Pharma Inc. shares at an average US$27.84 for US$1.46M under a trading plan, leaving 0 shares. Filed Nov 19, 2026 (Form 4).
- Sold
- 52,500 shares
- Price
- US$27.84 average (US$27.76 to US$29.22)
- Value
- US$1.46M
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Common Stock | Option exercise | 45,300 | US$4.62 | 45,300 | Direct |
| Nov 17, 2026 | Common Stock | Sale | 39,600 | US$27.76 | 5,700 | Direct |
| Nov 17, 2026 | Common Stock | Sale | 5,300 | US$28.15 | 400 | Direct |
| Nov 17, 2026 | Common Stock | Sale | 400 | US$29.22 | 0 | Direct |
| Nov 18, 2026 | Common Stock | Option exercise | 7,200 | US$4.62 | 7,200 | Direct |
| Nov 18, 2026 | Common Stock | Sale | 6,465 | US$27.90 | 735 | Direct |
| Nov 18, 2026 | Common Stock | Sale | 735 | US$28.36 | 0 | Direct |
Source
Download original · View original at SEC